Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-406-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 Mar 2016 to 08 Apr 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study without restrictions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (adopted 1992)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- (Official Journal of the European Union No. L142, May 2008, including most recent amendments)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- (March 2003)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF Guidelines (12 Nousan, Notification No 8147, Nov 2000, including the most recent revisions)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 2-(N-methyldodecanamido)acetic acid 2-hydroxypropan-1-aminium 2-(N-methyldodecanamido)acetate
- EC Number:
- 943-406-1
- Molecular formula:
- Not applicable. This substance is UVCB.
- IUPAC Name:
- 2-(N-methyldodecanamido)acetic acid 2-hydroxypropan-1-aminium 2-(N-methyldodecanamido)acetate
- Test material form:
- liquid: viscous
- Details on test material:
- - Name of test material (as cited in study report): MIPA-Cocoyl-Sarkosinat
- Substance type: organic (UVCB)
- Physical state: clear yellow-brown viscous liquid
- Analytical purity: 100%, according to definition of UVCB
- Impurities (identity and concentrations): no impurities, UVCB
- Lot/batch No.: 070715
- Expiration date of the lot/batch: 31 Dec 2016
- Stability under test conditions: stable in vehicle water
- Storage condition of test material: at room temperature
- Other: pH 5.7 - 6.0 (1% in water)
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L'Arbresle, France
- Age at study initiation: approx. 4 weeks old
- Weight at study initiation: 248 - 288 g
- Housing: Group housing of maximally 5 animals per labeled Noryl cage (Tecniplast; 74 cm x 54 cm x 25 cm height) containing sterilised sawdust as bedding material (Lignocel S 8-15. JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) and shelters (CS3B02A Play tunnels (90 mm x 5 mm x 125 mm), Datesand, Manchester, UK) as cage enrichment.
- Diet: Complete maintenance diet for guinea pigs (SSNIFF Spezialitäten GmbH, Soest, Germany). In addition, hay (TecniLab-BMI BV, Someren, The Netherlands) was provided at least twice a week.
- Water: Tap water, ad libitum
- Acclimation period: at least 2 days prior to start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 24 °C
- Humidity (%): 40 - 70%
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction:
Intradermal: 0.1%
Epicutaneous: 2%
Challenge:
Epicutaneous: 2%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Induction:
Intradermal: 0.1%
Epicutaneous: 2%
Challenge:
Epicutaneous: 2%
- No. of animals per dose:
- 10 test group
5 control - Details on study design:
- RANGE FINDING TESTS:
Series of test item concentrations were tested. The starting and subsequent concentrations were taken from the series: 100% (undiluted), 50%, 20%, 10%, 5%, 2%, 1%, and further lower concentrations using the same steps.
A series of eight test item concentrations was tested for intradermal injection, the highest concentration being the maximum technically injectable concentration (20%). Each of four animals received two different concentrations in duplicate (0.1 mL/site) in the clipped scapular region. The injection sites were assessed for irritation 24 and 48 h after treatment.
A series of four test item concentrations was tested for epidermal application, the highest concentration being the maximum concentration that could technically be applied (100%). Two different concentrations were applied (0.5 mL each) per animal to the clipped flank, using Metalline patches (2 x 3 cm) mounted on Medical tape which were held in place with Micropore tape and subsequently Coban elastic bandage. After 24 h occlusive, the dressing was removed and the skin cleaned of residual test item using water. The treated skin areas were assessed for irritation 24 and 48 h after removal of the dressings. Based on the results in the initially treated animals, two additional animals were epidermally treated in a similar manner with two lower concentrations at a later stage.
The concentrations and induction method in the main study were selected based on the results of the preliminary irritation study.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epidermal)
- Exposure period: Day 1 to Day 10 (Intradermal induction on Day 1, epidermal exposure from Day 8 to Day 10)
- Test group: Intradermal: 3 pairs of injections in the clipped scapular region (0.1 mL/site): A) 1:1 w/w mixture of Freunds' Complete Adjuvant with water for injection B) Test item at 0.1% C) 1:1 w/w mixture of test item at 0.2% and Freunds' Complete Adjuvant
Epidermal: Application of 0.5 mL of 2% test item concentration under occlusive dressing using a Metalline patch (2 x 3cm) mounted on Medical tape, which was held in place with Micropore tape and subsequently Coban elastic bandage.
- Control group: Treated as described for test group except that, instead of test item, the vehicle was administered in analogous fashion.
- Site: Clipped scapular region
- Frequency of applications: Intradermal injection once, epidermal application once
- Duration: Epidermal application for 48 h under occlusive dressing
- Concentrations: Intradermal 0.1%, epidermal 2%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 21
- Exposure period: 24 hours
- Test groups: Epidermal application of 2% test item concentration and vehicle (0.1 mL each) under occlusive conditions, using two Patch Test Plasters (Curatest, Lohmann, Almere, The Netherlands) approximately 2 cm apart, mounted on Medical tape. The patches were held in place with Micropore tape and subsequently Coban elastic bandage.
- Control group: Treated in analogous fashion to the test group.
- Site: Clipped flank (one side only)
- Concentrations: 2%
- Evaluation (hr after challenge): 24 and 48 hours after removal of the dressing (i.e. 48 and 72 hours after challenge application) - Challenge controls:
- The control group actually satisfied the requirements of a challenge control as these animals had not been in contact with the test item prior to challenge, and the treatment with water and FCA in the induction phase is not supposed to induce any sensitisation reactions due to lack of antigens. However, FCA is known to have the potential to lower the irritation threshold which could be reflected by observation of irritation reactions at the challenge concentration determined as non-irritating in the range-finding study. That is a plausible explanation for the observation of scaliness in 1/5 control animals 48 hours after removal of the challenge patch.
- Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde, assessed in regular intervals to check the reliability of the experimental techniques (last check April 2016: Intradermal induction 1% concentration, epidermal induction 50% concentration, challenge 20% concentration)
Results and discussion
- Positive control results:
- In the positive control experiment a sensitisation rate of 33% to a challenge concentration of 20% alpha-hexylcinnamaldehyde was observed.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 2% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 2% challenge. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2% induction + 2% challenge
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- Scaliness in animal with positive reaction (grade 1)
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 2% induction + 2% challenge. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: Scaliness in animal with positive reaction (grade 1).
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50% induction + 20% challenge
- No. with + reactions:
- 3
- Total no. in group:
- 9
- Clinical observations:
- no data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 50% induction + 20% challenge. No with. + reactions: 3.0. Total no. in groups: 9.0. Clinical observations: no data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 2% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Scaliness in 1/5 animals
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 2% challenge. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Scaliness in 1/5 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2% induction + 2% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Scaliness in 6/10 animals
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 2% induction + 2% challenge. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Scaliness in 6/10 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50% induction + 20% challenge
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Clinical observations:
- no data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 50% induction + 20% challenge. No with. + reactions: 1.0. Total no. in groups: 9.0. Clinical observations: no data.
Any other information on results incl. tables
Observations:
Toxicity/Mortality: No mortality occurred and no symptoms of toxicity were observed in the animals of the main study.
Body weights: Body weights and body weight gain of experimental animals remained in the same range as controls over the study period (see Table 1).
Table 1: Body weights (gram)
Group |
Animal no. |
Day 1 |
Day 24 |
Control |
|||
|
26 |
266 |
371 |
|
27 |
265 |
383 |
|
28 |
264 |
385 |
|
29 |
268 |
450 |
|
30 |
252 |
381 |
|
Mean ± SD |
263 ± 6 |
394 ± 32 |
Test |
|||
|
31 |
257 |
414 |
|
32 |
248 |
379 |
|
33 |
280 |
408 |
|
34 |
275 |
389 |
|
35 |
283 |
417 |
|
36 |
288 |
419 |
|
37 |
248 |
357 |
|
38 |
273 |
393 |
|
39 |
273 |
409 |
|
40 |
266 |
401 |
|
Mean ± SD |
269 ± 14 |
399 ± 20 |
Conclusion:
The skin reactions other than scaliness observed in response to a 2% test item concentration in one (out of the ten) test animal in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results indicate a sensitisation rate of 10 percent.
Based on these results the test item does not have to be considered as sensitiser according to the criteria outlined In OECD guideline 406.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.